AKYA
Akoya Biosciences Inc

271
Loading...
Loading...
News
all
press releases
Akoya Biosciences (AKYA) Reports Q1 Loss, Misses Revenue Estimates
Zacks·5mo ago
News Placeholder
More News
News Placeholder
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SSTK, AKYA, POAI on Behalf of Shareholders
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SSTK, AKYA, POAI on Behalf of Shareholders SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SSTK, AKYA, POAI on Behalf of Shareholders...
PR Newswire·9mo ago
News Placeholder
AKOYA BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick and Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Akoya Biosciences, Inc. - AKYA
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (KSF) are investigating the proposed sale of Akoya Biosciences, Inc. (NasdaqGS: AKYA) to...
Business Wire·9mo ago
News Placeholder
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates ESSA, AKYA, CCNE, QTRX on Behalf of Shareholders
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates ESSA, AKYA, CCNE, QTRX on Behalf of Shareholders SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates ESSA, AKYA, CCNE, QTRX on Behalf of Shareholders...
PR Newswire·9mo ago
News Placeholder
Shareholder Alert: Ademi LLP Investigates Whether Akoya Biosciences, Inc. Is Obtaining a Fair Price for Its Public Shareholders
Ademi LLP is investigating Akoya (NASDAQ: AKYA) for possible breaches of fiduciary duty and other violations of law in its transaction with Quanterix. Click here to learn how to join our...
Business Wire·9mo ago
News Placeholder
AKYA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Akoya Biosciences, Inc. Is Fair to Shareholders
Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Akoya Biosciences, Inc. (NASDAQ: AKYA) to Quanterix Corporation for 0.318 shares of Quanterix common stock for each...
Business Wire·9mo ago
News Placeholder
Biotech Advances Drive Cancer Research as Global Rates Continue Upward Trend
Biotech Advances Drive Cancer Research as Global Rates Continue Upward Trend Biotech Advances Drive Cancer Research as Global Rates Continue Upward Trend PR Newswire VANCOUVER, BC, Dec. 2, 2024 USA...
PR Newswire·10mo ago
News Placeholder
Analyst Scoreboard: 4 Ratings For Akoya Biosciences
Latest Ratings for AKYA DateFirmActionFromTo Feb 2022Morgan StanleyMaintainsOverweight May 2021Canaccord GenuityInitiates Coverage OnBuy May 2021JP MorganInitiates Coverage OnOverweight View...
Benzinga·1y ago
News Placeholder
Akoya Biosciences Showcases Spatial Biology 2.0 Solutions at AACR Annual Meeting with Case Studies Demonstrating Unprecedented Speed and Scale
MARLBOROUGH, Mass., April 05, 2024 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc., (Nasdaq: AKYA), The Spatial Biology Company , today announced it will highlight case studies featuring its Spatial...
Globe Newswire·1y ago
News Placeholder
Akoya BioSciences (AKYA, $4.63) entered Downtrend as Momentum indicator drops below 0 level on Mar 26, 2024
This indicator may be signaling that AKYA's price has further to drop, since it moved below its price 14 days ago. Traders may consider selling the stock, shorting the stock, or exploring put options...
Tickeron - Stocks·2y ago

Latest AKYA News

View

Advertisement|Remove ads.

Advertisement|Remove ads.